Article
Ligand-receptor pair-based signature score Derived from On-treatment Tumor Specimens Predicts Immune Checkpoint Blockade Response in Metastatic Melanoma
2025-04-17
Abstract excerpt
<title>Abstract</title> <p>Immune checkpoint blockade (ICB) therapy has transformed the treatment landscape for metastatic melanoma, yet predicting therapeutic response remains a significant challenge. This study hypothesizes that coordinated ligand-receptor (LR) interactions within the tumor microenvironment (TME) critically influence ICB efficacy and proposes that a novel LR pair-based signature score (LRPS) de...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 72b10b05-6265-5e37-8db2-ea7f9ed8669a
- DOI
- 10.21203/rs.3.rs-5854916/v1
